HeartWare International, Inc. 4

4 · HeartWare International, Inc. · Filed Feb 25, 2016

Form 4

Period: 2016-02-23

Chief Scientifc Officer

Transactions

Sale
Common Stock
2016-02-24$32.41/sh−205$6,644→ 11,636 total
Exercise/Conversion
Restricted Stock Unit
2016-02-23−750→ 10,450 total
From: 2016-02-23Exp: 2016-02-23→ Common Stock (750 underlying)
Exercise/Conversion
Common Stock
2016-02-23+750→ 11,841 total

Footnotes (4)

[F1]On February 23, 2015, the reporting person was granted restricted stock units to acquire 3,000 shares of HeartWare International common stock. The award vests in four equal annual installments commencing on February 23, 2016. On February 23, 2016, 750 shares of common stock were issued to the reporting person.
[F2]These shares were sold pursuant to a pre-arranged trading plan in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The sale proceeds were utilized to pay all payroll taxes related to the vesting of restricted stock units and receipt of the related shares reported on this Form 4.
[F3]The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $32.25 to $32.57. The reporting person has provided the issuer and will provide any security holder of the issuer or the SEC Staff, upon request, information regarding the number of shares sold at each price within the range.
[F4]Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

Documents

1 file